BiotechTube
Home/Bausch Health/Thomas J. Appio
TJ

Thomas J. Appio

Chief Executive Officer

Bausch Health

Therapeutic Areas

GastroenterologyDermatology/Aesthetics

Bausch Health Pipeline

DrugIndicationPhase
XIFAXAN (rifaximin)Pediatric Irritable Bowel Syndrome with Diarrhea (IBS-D)Phase 3
AmiselimodModerate to Severe Ulcerative ColitisPhase 2
RelamorelinDiabetic GastroparesisPhase 2

Leadership Team at Bausch Health

SE
Sam Eldessouky
Chief Financial Officer
RS
Robert Spurr
President, Salix Pharmaceuticals
BS
Brett Shulman
President, Solta Medical
View full Bausch Health profile